🔴 BreakingDrug approvalRSSApr 3
FDA Approves Fourth Product Under National Priority Voucher Program, Higher Dose Semaglutide
The FDA approved a new, stronger version of the weight loss drug Wegovy (semaglutide) at 7.2 mg. This higher dose is intended for adults who need help losing weight and keeping it off long-term. This approval was granted under a special FDA program that prioritizes treatments for rare diseases.
WHY IT MATTERSThis approval under the National Priority Voucher Program suggests semaglutide may address weight management in a rare disease population, though the article does not specify which rare condition qualifies for this higher dose.
💬 Ask your doctorRead →